A detailed history of Amalgamated Bank transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 5,272 shares of RVMD stock, worth $228,224. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,272
Previous 5,272 -0.0%
Holding current value
$228,224
Previous $205,000 16.59%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$30.14 - $40.68 $11,001 - $14,848
365 Added 7.44%
5,272 $205,000
Q1 2024

Apr 23, 2024

SELL
$26.56 - $33.55 $360,897 - $455,877
-13,588 Reduced 73.47%
4,907 $158,000
Q4 2023

Feb 06, 2024

BUY
$18.35 - $34.12 $53,361 - $99,220
2,908 Added 18.66%
18,495 $530,000
Q3 2023

Nov 08, 2023

BUY
$25.17 - $35.05 $19,808 - $27,584
787 Added 5.32%
15,587 $431,000
Q2 2023

Aug 11, 2023

BUY
$20.28 - $27.0 $104,462 - $139,077
5,151 Added 53.38%
14,800 $395,000
Q1 2023

May 02, 2023

SELL
$20.76 - $30.09 $10,317 - $14,954
-497 Reduced 4.9%
9,649 $209,000
Q4 2022

Feb 10, 2023

BUY
$17.68 - $25.53 $3,200 - $4,620
181 Added 1.82%
10,146 $242,000
Q3 2022

Nov 09, 2022

BUY
$17.46 - $26.0 $29,210 - $43,498
1,673 Added 20.18%
9,965 $197,000
Q2 2022

Aug 15, 2022

BUY
$14.54 - $27.17 $11,195 - $20,920
770 Added 10.24%
8,292 $162,000
Q1 2022

Jun 30, 2022

SELL
$17.31 - $26.4 $9,797 - $14,942
-566 Reduced 7.0%
7,522 $192,000
Q4 2021

Feb 15, 2022

SELL
$24.35 - $33.7 $2,410 - $3,336
-99 Reduced 1.21%
8,088 $204,000
Q3 2021

Oct 29, 2021

SELL
$23.95 - $33.41 $13,435 - $18,743
-561 Reduced 6.41%
8,187 $225,000
Q2 2021

Aug 16, 2021

BUY
$29.0 - $47.44 $77,517 - $126,807
2,673 Added 44.0%
8,748 $278,000
Q1 2021

May 13, 2021

BUY
$37.21 - $54.43 $1,637 - $2,394
44 Added 0.73%
6,075 $279,000
Q4 2020

Feb 12, 2021

BUY
$30.19 - $45.49 $996 - $1,501
33 Added 0.55%
6,031 $238,000
Q3 2020

Oct 30, 2020

BUY
$22.61 - $34.8 $135,614 - $208,730
5,998 New
5,998 $209,000

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.8B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.